1. ScholarBank@NUS

New Lee Sun

rp06368

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
New Lee Sun
(not current staff)
Variants
New, L.S.
Lee, S.N.
New, L.-S.
 
Main Affiliation
 
Faculty
 
Email
phanls@nus.edu.sg
 

Publications

Results 1-20 of 24 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
15-Feb-2010A sensitive LC/MS/MS bioanalysis assay of orally administered lipoic acid in rat blood and brain tissueChng, H.T.; New, L.S. ; Neo, A.H.; Goh, C.W.; Browne, E.R.; Chan, E.C.Y. 
2Jun-2010Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytesSaha, S.; New, L.S. ; Ho, H.K. ; Chui, W.K. ; Chan, E.C.Y. 
328-Jan-2009Distribution study of orally administered lipoic acid in rat brain tissuesChng, H.T.; New, L.S. ; Neo, A.H.; Goh, C.W.; Browne, E.R.; Chan, E.C.Y. 
4Mar-2008Evaluation of BEH C18, BEH HILIC, and HSS T3 (C18) column chemistries for the UPLC-MS-MS analysis of glutathione, glutathione disulfide, and ophthalmic acid in mouse liver and human plasmaNew, L.-S. ; Chan, E.C.Y. 
5Dec-2007In vitro metabolism of leflunomide by mouse and human liver microsomes.Chan, E.C. ; New, L.S. 
6Jul-2012Interaction of lapatinib with cytochrome P450 3A5Chan, E.C.Y. ; New, L.S. ; Chua, T.B.; Yap, C.W. ; Ho, H.K. ; Nelson, S.D.
7Nov-2008Investigation of the drug-drug interaction between α-lipoic acid and valproate via mitochondrial β-oxidationPhua, L.C.; New, L.S. ; Goh, C.W.; Neo, A.H.; Browne, E.R.; Chan, E.C.Y. 
81-Feb-2010Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicitySaha, S.; New, L.S. ; Ho, H.K. ; Chui, W.K. ; Chan, E.C.Y. 
9Oct-2010Mechanism-based inactivation of cytochrome P450 3A4 by lapatinibTeng, W.C.; Oh, J.W.; New, L.S. ; Wahlin, M.D.; Nelson, S.D.; Ho, H.K. ; Chan, E.C.Y. 
10Jun-2011Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinibTakakusa, H.; Wahlin, M.D.; Zhao, C.; Hanson, K.L.; New, L.S. ; Chan, E.C.Y. ; Nelson, S.D.
111-Apr-2011Metabolic profiling of 3-nitropropionic acid early-stage huntingtons disease rat model using gas chromatography time-of-flight mass spectrometryChang, K.L.; New, L.S. ; Mal, M.; Goh, C.W.; Aw, C.C.; Browne, E.R.; Chan, E.C.Y. 
124-Dec-2009Metabolic profiling of rat brain and cognitive behavioral tasks: Potential complementary strategies in preclinical cognition enhancement researchGoh, D.P.Q.; Neo, A.H.; Goh, C.W.; Aw, C.C.; New, L.S. ; Chen, W.S.; Atcha, Z.; Browne, E.R.; Chan, E.C.Y. 
132013Optimizing hollow-fiber-based pharmacokinetic assay via chemical stability study to account for inaccurate simulated drug clearance of rifampicinNew, L.S. ; Lim, T.P.; Oh, J.W.; Cheah, G.J.S.; Kwa, A.L.; Chan, E.C.Y. 
14Aug-2008Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic conversion to its major metabolite, A77 1726Seah, Q.M.; New, L.-S. ; Chan, E.C.Y. ; Boelsterli, U.A.
1515-Feb-2009Pharmaceutical metabolite profiling using quadrupole/ion mobility spectrometry/time-of-flight mass spectrometryChan, E.C.Y. ; Lee, S.N. ; Chun, W.Y. ; Lin, T.G.
162007Pharmacokinetic study of intraperitoneally administered troglitazone in mice using ultra-performance liquid chromatography/tandem mass spectrometryNew, L.-S. ; Saha, S.; Boelsterli, U.A. ; CHAN CHUN YONG,ERIC ; Ong, M.M.K.
172007Pharmacokinetic study of intraperitoneally administered troglitazone in mice using ultra-performance liquid chromatography/tandem mass spectrometryNew, L.-S. ; Saha, S.; Ong, M.M.K.; Boelsterli, U.A.; Chan, E.C.Y. 
18Dec-2011Preclinical metabolism and disposition of SB939 (pracinostat), an orally active histone deacetylase inhibitor, and prediction of human pharmacokineticsJayaraman, R.; Reddy, V.P.; Pasha, M.K.; Wang, H.; Sangthongpitag, K.; Yeo, P.; Hu, C.Y.; Wu, X.; Xin, L.; Goh, E.; New, L.S. ; Ethirajulu, K.
1928-Aug-2008Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imineTan, S.C.; New, L.S. ; Chan, E.C.Y. 
2015-Dec-2012Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer propertiesSaha, S.; Chan, D.S.Z.; Lee, C.Y.; Wong, W.; New, L.S. ; Chui, W.K. ; Yap, C.W. ; Chan, E.C.Y. ; Ho, H.K.